

VCBeat Health Contact Us

China Healthcare Select

Vertical Industries 

Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory

Home HUTCHMED Presents Breakthrough Phase III ESLIM-02 Data for Soletrectinib in Warm Autoimmune Hemolytic Anemia at EHA 2026

HUTCHMED Presents Breakthrough Phase III ESLIM-02 Data for Soletrectinib in Warm Autoimmune Hemolytic Anemia at EHA 2026

Jun 12, 2026 08:18 CST Updated 08:32

Share:

HUTCHMED

Biopharmaceutical Manufacturer

vcbeatglobal@vcbeat.net 

SERVICES

Partnership Development Market Entry Advisory Ecosystem Engagement Advisory

COMPANY

About VCBeat Why VCBeat Contact Us

CHANNELS

China Healthcare Select Insights MNC China Lens Events VB100 GMPC

MORE

PRIVACY VCBEAT CHINA

© 2025 VCBeat. All rights reserved.